Nidia K. Saucedo-Moncada

Dr. Jose Eleuterio González University Hospital And School Of Medicine
Monterrey, NLE, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Journal: Transplantation and cellular therapy

Published: February 06, 2026

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Journal: Transplantation and cellular therapy

Published: February 06, 2026

Barriers to Allogeneic Hematopoietic Cell Transplantation in the Haploidentical Era: A Multicenter Intent-to-Transplant Analysis in a Middle-Income Country.

Barriers to Allogeneic Hematopoietic Cell Transplantation in the Haploidentical Era: A Multicenter Intent-to-Transplant Analysis in a Middle-Income Country.

Journal: Transplantation and cellular therapy

Published: August 25, 2025

Impact of HLA eplets mismatch load on outcomes of outpatient haploidentical-related stem cell transplantation from peripheral blood after reduced intensity conditioning.

Impact of HLA eplets mismatch load on outcomes of outpatient haploidentical-related stem cell transplantation from peripheral blood after reduced intensity conditioning.

Journal: Expert review of hematology

Published: June 23, 2025

Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study.

Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study.

Journal: Transplantation and cellular therapy

Published: June 19, 2025

Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico.

Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico.

Journal: JCO global oncology

Published: April 18, 2025

Anti-HLA class I donor-specific antibodies are associated with lower overall and event-free survival and late mortality in outpatient haploidentical-related stem cell transplantation from the peripheral blood.

Anti-HLA class I donor-specific antibodies are associated with lower overall and event-free survival and late mortality in outpatient haploidentical-related stem cell transplantation from the peripheral blood.

Journal: Human immunology

Published: December 13, 2024

Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.

Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: November 02, 2023

Physical, Mechanical, and Biological Properties of Fibrin Scaffolds for Cartilage Repair.

Physical, Mechanical, and Biological Properties of Fibrin Scaffolds for Cartilage Repair.

Journal: International journal of molecular sciences

Published: July 18, 2022

Artificial Scaffolds in Cardiac Tissue Engineering.

Artificial Scaffolds in Cardiac Tissue Engineering.

Journal: Life (Basel, Switzerland)

Published: June 20, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026